Skip to content

A Clinical Study to See The Effect of Mukhapaknashak Yoga in Mukhpaka in childrens

Randomised Control Clinical Trial to Evaluate Efficacy of Mukhapaknashak yog in Mukhpaka in Children. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085071
Enrollment
68
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue

Interventions

None listed

Sponsors

Dr Yogiraj Tongale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having signs and symptoms of mukhapak (toda, daha, raktavarnata, sphota, shopha) 2. Patients between the age group 05 to 12 years, irrespective of Gender, religion, socio-economic status will be selected randomly for the study 3. Patient having ulcer dimension less than 4 to 5 mm 4. Recurrent history of stomatitis.

Exclusion criteria

Exclusion criteria: 1. Traumatic injury of mouth (eg-Toothbrush, jagged teeth) 2. Inflammatory conditions of the oral cavity like gingivitis, pharyngitis, tonsillitis. 3. Patients duration of course suffering from any systemic illness which interfere the of duration course i.e. Asthma. 4. Patient having ulcer dimension more than 5 mm. 5. Diseases like handfoot and mouth etc

Design outcomes

Primary

MeasureTime frame
signs and symptoms of mukhapak like toda, daha, raktavarnata, sphota, shopha will be decreased, and patient will be relieved from mukhpakaTimepoint: 0 , 3rd and 7th day

Secondary

MeasureTime frame
NIL Timepoint: NIL

Countries

India

Contacts

Public ContactDr Mahesh Chaugule

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Reseach Centre Ashta

chaugulemahesh@gmail.com9921212722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026